LODDO, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 154.727
NA - Nord America 12.959
AS - Asia 5.113
SA - Sud America 750
AF - Africa 124
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 173.686
Nazione #
IT - Italia 151.830
US - Stati Uniti d'America 12.838
CN - Cina 1.844
SG - Singapore 1.802
UA - Ucraina 897
BR - Brasile 604
SE - Svezia 575
VN - Vietnam 417
DE - Germania 340
FI - Finlandia 298
GB - Regno Unito 279
FR - Francia 266
IN - India 257
HK - Hong Kong 184
KR - Corea 127
CA - Canada 69
IQ - Iraq 66
TR - Turchia 54
BD - Bangladesh 52
PK - Pakistan 45
MA - Marocco 43
JP - Giappone 41
AR - Argentina 39
NL - Olanda 39
RU - Federazione Russa 36
BE - Belgio 35
EC - Ecuador 30
JO - Giordania 30
AT - Austria 28
ID - Indonesia 28
MX - Messico 27
SA - Arabia Saudita 23
ES - Italia 22
VE - Venezuela 21
UZ - Uzbekistan 20
IR - Iran 19
PL - Polonia 19
ZA - Sudafrica 19
PH - Filippine 17
EG - Egitto 16
TW - Taiwan 15
CL - Cile 12
CO - Colombia 12
LT - Lituania 11
PY - Paraguay 11
TN - Tunisia 10
MY - Malesia 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
UY - Uruguay 8
AU - Australia 7
IL - Israele 7
PE - Perù 7
AZ - Azerbaigian 6
JM - Giamaica 6
KZ - Kazakistan 6
NG - Nigeria 6
DO - Repubblica Dominicana 5
IE - Irlanda 5
KE - Kenya 5
LV - Lettonia 5
OM - Oman 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
ET - Etiopia 4
GE - Georgia 4
MU - Mauritius 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
CH - Svizzera 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RO - Romania 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EU - Europa 2
GY - Guiana 2
LB - Libano 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
GR - Grecia 1
Totale 173.668
Città #
Cagliari 147.816
Uta 3.585
Fairfield 1.466
Woodbridge 1.216
Ashburn 1.184
Singapore 956
Houston 940
Chandler 882
Ann Arbor 645
Dallas 566
Seattle 564
Wilmington 552
Jacksonville 513
Cambridge 500
Boardman 494
San Jose 434
Nyköping 402
Beijing 340
Dearborn 301
Los Angeles 197
Nanjing 162
Helsinki 156
Hong Kong 149
Hefei 148
Lauterbourg 148
Ho Chi Minh City 139
Santa Clara 135
Shanghai 130
Boston 126
Buffalo 104
Seoul 102
New York 88
The Dalles 75
Hanoi 73
Council Bluffs 60
San Diego 57
Shenyang 55
São Paulo 53
Pune 51
Guangzhou 45
Jiaxing 41
Tianjin 41
Frankfurt am Main 40
Nanchang 40
Hebei 39
Milan 39
Munich 37
Redwood City 37
Sassari 37
Toronto 36
Dong Ket 34
Casablanca 33
Changsha 32
Mountain View 32
Brussels 31
Tokyo 31
Columbus 30
Atlanta 27
Orem 24
Verona 24
Jinan 23
London 23
Washington 23
Amman 22
Kunming 22
Nuremberg 20
Rio de Janeiro 20
Zhengzhou 20
Chicago 19
Orange 19
Stockholm 19
Da Nang 18
Norwalk 18
Tashkent 18
Warsaw 18
Redondo Beach 17
Amsterdam 16
Brooklyn 16
Manchester 16
Phoenix 16
San Francisco 16
Bengaluru 15
Chennai 15
Haiphong 15
Wuhan 15
Fuzhou 14
Ankara 13
Baghdad 13
Düsseldorf 13
Guayaquil 13
Auburn Hills 12
Hangzhou 12
Jakarta 12
Ningbo 12
Palermo 12
Porto Alegre 12
Queven 12
Vienna 12
Belo Horizonte 11
Denver 11
Totale 166.937
Nome #
Synthesis, structural characterization and biological evaluation of 4'-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides 3.664
Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives 3.417
Synthesis and antiviral activity of new phenylimidazopyridines and N-benzylidenequinolinamines derived by molecular simplification of phenylimidazo[4,5-g]quinolines 2.993
Activity of bis(7-hydroxycoumarin) Mannich bases against bovine viral diarrhoea virus 2.913
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 2.876
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents 2.672
N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)anilines: A novel class of anti-RSV agents 2.643
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents 2.641
Quinoxaline derivatives as new inhibitors of coxsackievirus B5 2.609
Dichloro-phenyl-benzotriazoles: a new selective class of human respiratory syncytial virus entry inhibitors 2.604
Benzimidazole derivatives endowed with potent antileishmanial activity 2.459
A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems 2.422
Synthesis and anti-HIV-1 evaluation of some novel MC-1220 analogs as non-nucleoside reverse transcriptase inhibitors 2.413
Synthesis and biological evaluation of (acyl)hydrazones and thiosemicarbazones obtained via in situ condensation of iminium salts with nitrogen-containing nucleophiles. 2.411
Synthesis of novel fluoro analogues of MKC442 as microbicides 2.410
Antiviral activities of 5-chlorobenzotriazole derivatives 2.176
1,2-benzisothiazol-3(2h)-one benzenesulfonamides targeting the hiv nucleocapsid proteins are potential microbicide candidates for the prevention of mucosal hiv transmission/acquisition 2.167
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles 2.095
A Computationally-Based Explanation for the Knocking Out Activity of the Microbicide MC1220 2.093
Facile synthesis of the NNRTI microbicide MC-1220 and synthesis of its phosphoramidate prodrugs 2.089
Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques 2.042
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors 2.030
Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives 2.028
Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation. 1.993
Design, synthesis, antiviral evaluation, and SAR studies of new 1-(phenylsulfonyl)-1H-pyrazol -4-yl-methylaniline derivatives. 1.908
Synthesis and antiviral evaluation of 1-[(2-Phenoxyethyl)oxymethyl] and 6-(3,5-Dimethoxybenzyl) analogues of HIV drugs emivirine and TNK-651 1.899
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 1.884
Synthesis and biological evaluation of new 3-phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones 1.863
9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp) 1.792
Synergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase 1.749
Preliminary anti-Coxsackie activity of novel 1-[4-(5,6-dimethyl(H)-1H(2H)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 1.738
Synthesis and evaluation of in vitro biological activity of 4-substituted arylpiperazine derivatives of 1,7,8,9-tetrachloro-10,10-dimethoxy-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione 1.735
Styrylbenzimidazoles. Synthesis and biological activity - part 3 1.735
null 1.667
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus 1.635
Further SAR studies on bicyclic basic merbarone analogues as potent antiproliferative agents 1.607
null 1.577
Results on different formulations of an NNRTI candidate (MC 1220) for application as topical microbicide 1.543
Antimicrobial activity of 10-(diphenylmethylene)-4-azatricyclo[5.2.1.0 2,6]dec-8-ene-3,5-dione derivatives 1.496
In vitro evaluation of the anti-HIV-1 activity of Liposomes and gel ingredients 1.478
2,3-dihydro-1,2-diphenyl-substituted 4H-pyridinone derivatives as new anti flaviviridae inhibitors 1.458
1,2-benzisothiazol-3(2H)-one benzenesulfonamides as new microbicide candidates for prevention of mucosal HIV infections 1.385
Synthesis and anti-HIV-1 activity of new fluoro-HEPT analogues: an investigation on fluoro versus hydroxy substituents 1.319
Syntheses and in vitro biologic screening 3 of 1-aryl-10H-[1,2,4]triazolo[30,40:3,4][1,2,4]triazino[5,6-b]indoles 1.258
In vitro evaluation of the anti-HIV-1 activity of liposomes and gel ingredients 1.251
Aryl nucleoside H-phosphonates. Part 15: Synthesis, properties and, anti-HIV activity of aryl nucleoside 50-a-hydroxyphosphonates 1.248
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives 1.220
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines. 1.205
A novel synthetic route for the anti-HIV drug MC-1220 and its analogues 1.179
null 1.150
Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus Macaques with RT-SHIV 1.142
Anti-BVDV activity evaluation of naphthoimidazole derivatives compared with parental imidazoquinoline compounds. 1.137
Platinum and palladium-triazole complexes as highly potential antitumor agents 1.115
Synthesis and in vitro anti-HIV activity of N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives using MTT method 1.098
null 1.096
Antiviral activity of benzotriazole based derivatives 1.088
Synthesis, in vitro antiproliferative and anti-HIV activity of new derivatives of 2-Piperazino-1,3-benzo[d]thiazoles 1.061
null 1.044
null 1.022
Potent flaviviridae inhibitors: targeted finger domain of RdRp. 1.014
Inhibition of enterovirus a71 by a novel 2-phenyl-benzimidazole derivative 1.014
null 1.009
Potent flaviviridae inhibitors: targeted finger domain of RdRp 1.007
null 994
In vitro evaluation of the anti-viral activity of Aryl and Heteroaryl-Azoenammines 990
null 950
Mystery unveiled: benzimidazole docks different domains in Flaviviridae 943
Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV) 939
Data from a phase IIb clinical trial evaluating valopicitabine (NM283) combined with pegylated interferon in treatment-naïve hepatitis C patients 924
null 896
null 895
null 868
null 857
null 840
null 833
Mystery Unveiled: Benzimidazole docks in different domains of HCV and BVDV RdRp 832
null 832
Synthesis, Antitumor and Antiviral In Vitro Activities of New Benzotriazole-Dicarboxamide Derivatives 829
null 786
null 760
Hepatitis C: New therapeutic approaches 752
null 737
Hindered nucleoside analogs as inhibitors of HCV RNA-dependent RNA polymerase: evolving vistas 735
null 732
(Hetero)aroyl esters of 2-(N-phthalimido)ethanol and analogues: parallel synthesis, anti-HIV-1 activity and cytotoxicity 727
null 717
null 712
null 694
Biological evaluation of 10-(diphenylmethylene)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione derivatives 687
Benzimidazoles as potent non nucleosidic inhibitors of Respiratory Syncytial Virus 645
Benzimidazole-2-Phenyl-Carboxamides as Dual-Target Inhibitors of BVDV Entry and Replication 633
Synthesis and antiproliferative acticity of basic thioanalogues of merbarone 628
Synthesis and in vitro antiproliferative activity of new benzothiazole derivatives 596
null 595
null 581
Erratum to: Syntheses and in vitro biological screening of 1-aryl-10 H-[1,2,4]triazolo[3′,4′:3,4][1,2,4]triazino[5,6-b]indoles 581
Synthesis and in vitro antiviral studies of bis(pivaloyloxymethyl)ester derivative of 9-[((phosphonomethyl)aziridin-1-yl)methyl]adenine(PMAMA) and analogues 574
Synthesis and in vitro antiproliferative activity of new adamantylthiazolyl-1,3,4-oxadiazoles 561
Design, synthesis, and antiviral activities of new benzotriazole-based derivatives 531
2-Arylbenzimidazoles as antiviral and antiproliferative agents-Part 1 524
Totale 141.596
Categoria #
all - tutte 231.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 231.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.622 0 0 0 0 0 0 0 0 0 1.533 1.320 769
2021/20229.286 1.122 754 429 653 814 756 501 459 1.008 822 971 997
2022/202313.159 1.260 1.425 1.335 995 1.155 1.352 723 857 981 1.015 1.377 684
2023/202417.171 624 965 938 1.330 1.794 2.593 2.665 1.248 762 1.046 1.645 1.561
2024/202528.017 6.778 7.458 3.279 2.949 1.577 1.734 2.647 213 378 271 326 407
2025/20269.039 576 453 1.172 821 777 798 1.707 1.111 792 832 0 0
Totale 174.205